Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Agilent Technologies, Inc. A

Healthcare  —  Diagnostics & Research
172.79 (0.05) (0.03%) as of 25 Sep
Market cap
$49.0B
P/E
33.9×
S&P 500 Member Dividend Champion (10y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Agilent Technologies, Inc. (A) EV/Sales

As of 25 September 2026, Agilent Technologies, Inc. (A) trades at a EV/Sales of 6.9×. Over the past ten years it has ranged from 2.2× (September 2015) to 9.1× (September 2021); the current reading is higher than 89% of that period. That is above the Diagnostics & Research industry median of 5.7× and above the Healthcare sector median of 3.6×.

EV/Sales, daily

Annual

Period EV/Sales Change
FY2025 6.2× 0.81%
FY2024 6.1× 32.49%
FY2023 4.6× (26.58%)
FY2022 6.3× (18.77%)
FY2021 7.7× 23.84%
FY2020 6.2× 33.35%
FY2019 4.7× 13.16%
FY2018 4.1× (11.93%)
FY2017 4.7× 42.99%
FY2016 3.3× 8.31%

Quarterly

Period EV/Sales Change
Jul 2026 5.5× 18.63%
Apr 2026 4.7× (16.56%)
Jan 2026 5.6× (9.05%)
Oct 2025 6.2× 21.56%
43 more quarters

Against its own ten years

Low 2.2× High 9.1×
Ten-year median 5.1×
Current reading's percentile 89

EV/Sales against peers

Company EV/Sales
DGX Quest Diagnostics Incorporated compare 2.7×
IQV IQVIA Holdings Inc. compare 3.5×
A Agilent Technologies, Inc. 6.9×
MTD Mettler-Toledo International, Inc. compare 7.9×
IDXX IDEXX Laboratories, Inc. compare 9.1×
ILMN Illumina, Inc. compare 9.3×
WAT Waters Corporation compare 10.1×
GH Guardant Health, Inc. compare 20.3×
NTRA Natera, Inc. compare 21.6×
Diagnostics & Research industry median 5.7×
Healthcare sector median 3.6×
Market median 2.2×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on A